Chris D. Alafi

Cybergold, Inc. provides direct marketing & advertising solutions for on-line advertisers and marketers. It provides internet-based direct marketing and advertising services with programs that reward consumers with cash when they perform actions desired by advertising and marketing clients. The services provided by the company primarily include production and development of marketing programs, delivery of targeted e-mail to its members, design of customer web sites and third party engineering functions. Cybergold was founded by Nat Goldhaber in 1995 and is located in Oakland, CA.

Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.

Alafi Capital Co. LLC (Alafi Capital) is a venture capital firm founded by Christopher alafi in 1995. The firm is headquartered in San Francisco, California.

ISTO Technologies, Inc. develops and markets clinical solutions for spinal therapy, sports medicine, and trauma. It develops biologic products to rebuild bone, and heal degenerated or damaged cartilage. The company was founded by Joseph Feder and Scott Gill in 1997 and is headquartered in St. Louis, MO.

Nuredis, Inc. develops treatments for neurodegenerative and neuromuscular diseases. The private company is based in Menlo Park, CA. The company was founded by Stanley N. Cohen.